Market Exclusive

AbbVie Inc. (NYSE:ABBV) reported earnings of $1.41 per share beating Walls Streets expectations.

AbbVie Inc. (NYSE:ABBV) reported Q3 2017 earnings this Morning, coming in at $1.41 per share, beating Wall Street’s estimates of $1.39 per Share. Revenue for the quarter came in at $7.00 billion in-line expectations of $7.00 billion

Analyst Coverage For AbbVie Inc. (NYSE:ABBV)
These are 6 Hold Ratings, 10 Buy Ratings .
The current consensus rating for AbbVie Inc. (NYSE:ABBV) is Buy (Score: 2.63) with a consensus target price of $93.33 , a potential (4.21% upside)Recent Insider Trading for AbbVie Inc. (NYSE:ABBV)

Dividend History for AbbVie Inc. (NYSE:ABBV)

Recent Trading for AbbVie Inc. (NYSE:ABBV) Shares of AbbVie Inc. closed the previous trading session at with shares trading hands.

Exit mobile version